SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Doug DuBois who wrote (8342)3/3/1998 2:10:00 PM
From: BigLouie  Read Replies (1) | Respond to of 14328
 
She meant it would do very little for the bottomline. Publicity - I
agree it would be positive - but - take notice over the last several months, TRIBY has not been without publicity items - none of which
indicated market size or projected sales/revenue/profit.

My opinion is that institutional ownership is the missing ingredient
-and this forum can do little to effect it - unfortunately. M



To: Doug DuBois who wrote (8342)3/3/1998 4:19:00 PM
From: nic  Respond to of 14328
 
the FDA approval would mean very little

Olga may have made that statement in light of the past US policy on HIV testing/counseling, which left no market for the rapid tests. This appears to be changing.

- nic


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News